Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Torgerson, Paul R ^a   Hagan, José E ^b,c   Costa, Federico ^b,c,d   Calcagno, Juan ^b   Kane, Michael ^c   Martinez Silveira, Martha S ^b   Goris, Marga G A ^e   Stein, Claudia ^f   Ko, Albert I ^b,c   Abela Ridder, Bernadette ^f  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c YALE UNIVERSITY   (United States)

^d FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^e ROYAL TROPICAL INSTITUTE   (Netherlands)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DISABILITY ADJUSTED LIFE YEAR; DISABILITY WEIGHT; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; LEPTOSPIROSIS; LIFE EXPECTANCY; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; PREGNANT WOMAN; SENSITIVITY ANALYSIS; UVEITIS; COST OF ILLNESS; DISABILITY; HEALTH; MORTALITY; QUALITY ADJUSTED LIFE YEAR; UNCERTAINTY;

COST OF ILLNESS; DISABILITY EVALUATION; FEMALE; GLOBAL HEALTH; HUMANS; LEPTOSPIROSIS; MALE; QUALITY-ADJUSTED LIFE YEARS; UNCERTAINTY;

EID: 84956488642     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004122     Document Type: Article

References (31)

1. Ko AI, Goarant C, Picardeau M, Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol. 2009;7: 736–747. doi: 10.1038/nrmicro220819756012
2. Levett PN, Leptospirosis. Clin Microbiol Rev. 2001;14: 296–326. 11292640
3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3: 757–771. 14652202
4. Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N, The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2008;12: 351–357.
5. Biggs HM, Bui DM, Galloway RL, Stoddard RA, Shadomy SV, Morrissey AB, et al. Leptospirosis among hospitalized febrile patients in northern Tanzania. Am J Trop Med Hyg. 2011;85: 275–281. doi: 10.4269/ajtmh.2011.11-017621813847
6. Wuthiekanun V, Sirisukkarn N, Daengsupa P, Sakaraserane P, Sangkakam A, Chierakul W, et al. Clinical Diagnosis and Geographic Distribution of Leptospirosis, Thailand. Emerg Infect Dis. 2007;13: 124–126. 17370525
7. Ko AI, Galvão Reis M, Ribeiro Dourado CM, Johnson WD, JrRiley LW, Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999;354: 820–825. 10485724
8. Gouveia EL, Metcalfe J, de Carvalho ALF, Aires TSF, Villasboas-Bisneto JC, Queirroz A, et al. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis. 2008;14: 505–508. doi: 10.3201/eid1403.07106418325275
9. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis Off Publ Infect Dis Soc Am. 1999;29: 1561–1563.
10. Ismail TF, Wasfy MO, Abdul-Rahman B, Murray CK, Hospenthal DR, Abdel-Fadeel M, et al. Retrospective Serosurvey of Leptospirosis Among Patients with Acute Febrile Illness and Hepatitis in Egypt. Am J Trop Med Hyg. 2006;75: 1085–1089. http://www.ajtmh.org/content/75/6/108517172371
11. Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, et al. Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Negl Trop Dis. 2013;7: e2324. doi: 10.1371/journal.pntd.000232423875053
12. Clement J, Neild G, Hinrichsen SL, Crescente JA, Van Ranst M, Urban leptospirosis versus urban hantavirus infection in Brazil. The Lancet. 1999;354: 2003–2004.
13. Suttinont C, Losuwanaluk K, Niwatayakul K, Hoontrakul S, Intaranongpai W, Silpasakorn S, et al. Causes of acute, undifferentiated, febrile illness in rural Thailand: results of a prospective observational study. Ann Trop Med Parasitol. 2006;100: 363–370. 16762116
14. Souza VMM de, Arsky M de LNS, Castro APB de, Araujo WN de, Years of potential life lost and hospitalization costs associated with leptospirosis in Brazil. Rev Saúde Pública. 2011;45: 1001–1008. 21953079
15. Stein C, Kuchenmüller T, Hendrickx S, Prüss-Ustün A, Wolfson L, Engels D, et al. The Global Burden of Disease assessments—WHO is responsible?PLoS Negl Trop Dis. 2007;1: e161. 18160984
16. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380: 2197–2223. doi: 10.1016/S0140-6736(12)61689-423245608
17. WHO | Leptospirosis Burden Epidemiology Reference Group (LERG). In: WHO [Internet]. [cited 22 Nov 2013]. http://www.who.int/zoonoses/diseases/lerg/en/
18. Costa F, Hagan José, Calcagno J, Kane M, Torgerson PR, Matinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015; 9: e3898. doi: 10.1371/journal.pntd.0003898
19. Murray CJ, Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72: 429–445. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2486718/8062401
20. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. The Lancet. 2012;380: 2063–2066.
21. World Urbanization Prospects: The 2009 Revision Population Database [Internet]. [cited 21 Nov 2013]. http://esa.un.org/wup2009/unup/index.asp?panel=1
22. Carles G, Montoya E, Joly F, Peneau C, Leptospirosis and pregnancy: A series of 11 cases in French Guiana. J Gynecol Obstet Biol Reprod (Paris). 1995;24: 418–421.
23. Shaked Y, Shpilberg O, Samra D, Samra Y, Leptospirosis in Pregnancy and Its Effect on the Fetus—Case-Report and Review. Clin Infect Dis. 1993;17: 241–243. 8399874
24. Torgerson PR, Mastroiacovo P, The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91: 501–508. doi: 10.2471/BLT.12.11173223825877
25. Kortbeek LM, Hofhuis A, Nijhuis CDM, Havelaar AH, Congenital toxoplasmosis and DALYs in the Netherlands. Mem Inst Oswaldo Cruz. 2009;104: 370–373. http://www.ncbi.nlm.nih.gov/pubmed/1943066619430666
26. WHO. Report of the Second Meeting of the Leptospirosis Burden Epidemiology Reference Group. Geneva, Switzerland; 2011 p. 37.
27. Goris MGA, Kikken V, Straetemans M, Alba S, Goeijenbier M, van Gorp ECM, et al. Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands. PLoS ONE. 2013;8: e76549. doi: 10.1371/journal.pone.007654924098528
28. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet. 2012;380: 2129–2143.
29. Pappachan J, Mathew S, Thomas B, Renjini K, Scaria C, Shukla J, The incidence and clinical characteristics of the immune phase eye disease in treated cases of human leptospirosis. Indian J Med Sci. 2007;61: 441. 17679733
30. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, et al. Estimating the Global Burden of Endemic Canine Rabies. PLoS Negl Trop Dis. 2015;9: e0003709. doi: 10.1371/journal.pntd.000370925881058
31. Manock SR, Jacobsen KH, Bravo NB de, Russell KL, Negrete M, Olson JG, et al. Etiology of Acute Undifferentiated Febrile Illness in the Amazon Basin of Ecuador. Am J Trop Med Hyg. 2009;81: 146–151. http://www.ajtmh.org/content/81/1/14619556580